Stay updated on Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer

Sign up to get notified when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the Study Details page for NCT02580058. The content remains focused on trial design, eligibility, interventions, and outcomes.
    Difference
    0.1%
    Check dated 2025-10-31T12:06:11.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Core content updated with government funding status and operating details; version bumped to v3.2.0. Deletion of a specific resource listing (Genetic and Rare Diseases Information Center resources: Ovarian cancer) and removal of the older revision tag (v3.0.2).
    Difference
    1%
    Check dated 2025-10-02T19:46:44.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Removed a 'Back to Top' link; no significant content or data changes.
    Difference
    0.0%
    Check dated 2025-09-18T06:46:32.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added MedlinePlus Genetics topic: Ovarian cancer and updated to revision v3.0.2; removed the previous revision tag v3.0.0-post.1-g752effb-HEAD.
    Difference
    0.1%
    Check dated 2025-09-11T02:13:40.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page has undergone a version update from v3.0.0 to v3.0.0-post.1-g752effb-HEAD, and the section on Ovarian cancer from MedlinePlus Genetics has been removed.
    Difference
    0.1%
    Check dated 2025-09-03T22:21:24.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous locations related to ovarian cancer studies across various countries, and the removal of outdated location references. Additionally, the study now lists 295 locations, down from 296, indicating a slight adjustment in the data presented.
    Difference
    18%
    Check dated 2025-08-27T18:45:22.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.